UK-based contract research organization (CRO) Chiltern International opened a new office in Budapest, Hungary.
The new location, the company's first in Hungary, will be overseen by Attila Lorinczi, a member of the Hungarian Medical Society and the Society of Hungarian Urologists. Lorinczi has 13 years of experience in the pharmaceutical industry, most recently working as a clinical operations manager.
Chiltern also opened an office in Brussels, Belgium, in June.
"Central and Eastern Europe continues to be a key focus for our clinical trials, and Hungary is an important component of this region. We are delighted to show our continual regional growth in line with our strategy for increased global coverage," said Lewis Cameron, Chiltern's executive vice president for Europe.
With the opening of the Hungary office, the CRO provides phase I to phase IV services in 28 countries.